Biomarkers in Cardiovascular Diseases

Herausgeber: Tousoulis, Dimitris; Stefanadis, Christodoulos

• Gebundenes Buch

Produktbeschreibung

The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians. The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: CRC Press
• Seitenzahl: 452
• Erscheinungstermin: 29. Juli 2013
• Englisch
• Abmessung: 240mm x 161mm x 29mm
• Gewicht: 840g
• ISBN-13: 9781466587144
• ISBN-10: 1466587148
• Artikelnr.: 37185503

Autorenporträt

Dimitris Tousoulis, Christodoulos Stefanadis

Inhaltsangabe

Part I: Classical biomarkers: C-reactive protein in cardiovascular disease.
Biomarkers in early atherosclerosis. Biomarkers in essential hypertension.
Biomarkers in hyperlipidemia. Cardiac biomarkers in acute coronary
syndromes. Biomarkers in congestive heart failure. Biomarkers of Pulmonary
Hypertension and Pulmonary Embolism. Coronary artery by-pass grafting and
biomarkers. Biomarkers of peripheral arterial disease. Biomarkers in
cardiorenal syndrome. Cardiac arrhythmias: is there a role for biomarkers?.
The role of biomarkers in the antiplatelet treatment. Part II: Novel
biomarkers: Novel biomarkers used in the assessment of acute coronary
syndrome. Novel cardiac biomarkers and application to heart failure. The
role of genetic traits in cardiovascular disease. MicroRNAs: a novel
cardiac biomarker.